REMISSION-INDUCTION, CONSOLIDATION AND MAINTENANCE THERAPY BY AVA PROTOCOL IN ACUTE NONLYMPHOBLASTIC LEUKEMIA

被引：0
|
作者：
TORLONTANO, G
GERACI, L
LOMBARDO, M
DIMARZIO, A
IACONE, A
FIORITONI, G
BONANNI, G
DIBARTOLOMEO, P
BALLONE, E
DANTONIO, D
DIGIROLAMO, G
DARCANGELO, L
PANDOLI, G
NATALE, D
SPADANO, A
机构：
[1] UNIV CHIETI,CATTEDRA EMATOL,CHIETI,ITALY
[2] UNIV CHIETI,CATTEDRA IGIENE,CHIETI,ITALY
来源：
HAEMATOLOGICA | 1982年 / 67卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：230 / 245
页数：16
相关论文
共 50 条
  • [31] INVASIVE FUNGAL DISEASE IN ADULTS UNDERGOING REMISSION-INDUCTION THERAPY FOR ACUTE MYELOID-LEUKEMIA - THE PATHOGENETIC ROLE OF THE ANTILEUKEMIC REGIMEN
    BOW, EJ
    LOEWEN, R
    CHEANG, MS
    SCHACTER, B
    CLINICAL INFECTIOUS DISEASES, 1995, 21 (02) : 361 - 369
  • [32] CAMAL - A NEW PROGNOSTIC MARKER FOR REMISSION IN ACUTE NONLYMPHOBLASTIC LEUKEMIA
    LOGAN, PM
    WHITNEY, S
    NAIMAN, S
    LEVY, JG
    LEUKEMIA RESEARCH, 1988, 12 (01) : 19 - 24
  • [33] REMISSION MAINTENANCE OF ACUTE NONLYMPHOBLASTIC LEUKEMIA WITH BCNU (NSC-409962) AND CYCLOPHOSPHAMIDE (NSC-26271)
    MANASTER, J
    COWAN, DH
    CURTIS, JE
    HASSELBACK, R
    BERGSAGEL, DE
    CANCER CHEMOTHERAPY REPORTS PART 1, 1975, 59 (03): : 537 - 545
  • [34] Cytotoxic therapy-induced D-xylose malabsorption and invasive infection during remission-induction therapy for acute myeloid leukemia in adults
    Bow, EJ
    Loewen, R
    Cheang, MS
    Shore, TB
    Rubinger, M
    Schacter, B
    JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (06) : 2254 - 2261
  • [35] LEUKEMIA P1798 AS A POSSIBLE EXPERIMENTAL MODEL FOR REMISSION INDUCTION AND REMISSION MAINTENANCE FOR ACUTE LEUKEMIA
    VADLAMUDI, S
    WARAVDEKAR, VS
    PADARATHSINGH, M
    GOLDIN, A
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1971, 12 (NMAR): : 16 - +
  • [36] HOMOHARRINGTONINE - AN EFFECTIVE NEW DRUG FOR REMISSION INDUCTION IN REFRACTORY NONLYMPHOBLASTIC LEUKEMIA
    WARRELL, RP
    COONLEY, CJ
    GEE, TS
    JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (05) : 617 - 621
  • [37] IMPACT OF INVASIVE ASPERGILLOSIS OCCURRING DURING REMISSION-INDUCTION THERAPY ON OUTCOME OF ACUTE MYELOID LEUKEMIA (SEIFEM 2012B STUDY).
    Candoni, A.
    Farina, F.
    Perruccio, K.
    Di Blasi, R.
    Criscuolo, M.
    Cattaneo, C.
    Delia, M.
    Lazzarotto, D.
    Dragonetti, G.
    Fanci, R.
    Martino, B.
    Del Principe, M. I.
    Potenza, L.
    Vianelli, N.
    Chierichini, A.
    Garzia, M.
    Nadali, G.
    Verga, L.
    Dubbini, M. V.
    Busca, A.
    Pagano, L.
    HAEMATOLOGICA, 2019, 104 : 30 - 30
  • [38] RELATIONSHIP BETWEEN THE PER CENT OF MARROW-CELLS IN S-PHASE AND THE OUTCOME OF REMISSION-INDUCTION THERAPY FOR ACUTE NONLYMPHOCYTIC LEUKEMIA
    PREISLER, HD
    AZARNIA, N
    RAZA, A
    GRUNWALD, H
    VOGLER, R
    BROWMAN, G
    GOLDBERG, J
    CHERVENICK, P
    MILLER, K
    BRENNAN, J
    WINTON, L
    JOYCE, R
    GOTTLIEB, A
    BRITISH JOURNAL OF HAEMATOLOGY, 1984, 56 (03) : 399 - 407
  • [39] RAPID REMISSION INDUCTION AND INTENSIVE CONSOLIDATION IN ACUTE NONLYMPHOCYTIC LEUKEMIA (ANNL) IN ADULTS
    CASSILETH, PA
    KAHN, SB
    SILBER, R
    WEILER, CB
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 433 - 433
  • [40] HEPATIC DRUG CLEARANCE IN CHILDREN WITH LEUKEMIA - CHANGES IN CLEARANCE OF MODEL SUBSTRATES DURING REMISSION-INDUCTION THERAPY
    RELLING, MV
    CROM, WR
    PIEPER, JA
    CUPIT, GC
    RIVERA, GK
    EVANS, WE
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 41 (06) : 651 - 660
12345